Post by
QContinuum1 on Aug 14, 2024 7:16am
Q2 Results
Meh. Issue isn't that they're meh, issue is that they can't grow top line (especially in Germany) when others are doing so. This business isn't going anywhere. Let the selloff commence.
Comment by
Macpoor on Aug 14, 2024 7:23am
Rom was not a day! Building a business takes time. Think about Amazon, 3o years ago was a tiny company but today is a different ballgame. So LABS has products and there are demands for it.
Comment by
Macpoor on Aug 14, 2024 8:12am
I am waiting what the management team will say in an hour. I hope that they give us a clear message for upcoming months ahead. You never know . The world of stock market is full of surprises and ambiguities! At the end , I just wish to have power to move those stock to at least over 30 cents:)) Good luck!
Comment by
CADInvestor12 on Aug 14, 2024 8:36am
Inbetween meh & good, unfortunately no catalysts in PR/ MD&A that we were hoping for. Issue with top line is from Canadian market .. for whatever reason, they cannot profitably grow their domestic portfolio. Germany grew 70% QoQ & Australia 16% .. WTF is going on in Brazil
Comment by
QContinuum1 on Aug 14, 2024 8:47am
But they only grew in Germany because of Drobaninol. That is not good enough.